CL2009000164A1 - Envase de dosificacion para una composicion farmaceutica al menos en dosis diferentes, comprende al menos dos configuraciones tipo caja conectadas entre si, cada una con al menos 3 regiones, cada region comprende una composicion farmaceutica, con distancias entre dos regiones menores a distancias a otra configuracion - Google Patents

Envase de dosificacion para una composicion farmaceutica al menos en dosis diferentes, comprende al menos dos configuraciones tipo caja conectadas entre si, cada una con al menos 3 regiones, cada region comprende una composicion farmaceutica, con distancias entre dos regiones menores a distancias a otra configuracion

Info

Publication number
CL2009000164A1
CL2009000164A1 CL2009000164A CL2009000164A CL2009000164A1 CL 2009000164 A1 CL2009000164 A1 CL 2009000164A1 CL 2009000164 A CL2009000164 A CL 2009000164A CL 2009000164 A CL2009000164 A CL 2009000164A CL 2009000164 A1 CL2009000164 A1 CL 2009000164A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
distances
regions
box
different doses
Prior art date
Application number
CL2009000164A
Other languages
English (en)
Inventor
Diego M Arbaiza Taurel
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39456418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000164(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of CL2009000164A1 publication Critical patent/CL2009000164A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0481—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Envase de dosificación para una composición farmacéutica al menos en dosis diferentes, que comprende al menos 2 configuraciones, cada una con al menos 3 regiones dirigibles individualmente, donde cada región comprende una composición farmacéutica, en donde la dosis de la composición es la misma en cada configuración; equipo.
CL2009000164A 2008-01-28 2009-01-26 Envase de dosificacion para una composicion farmaceutica al menos en dosis diferentes, comprende al menos dos configuraciones tipo caja conectadas entre si, cada una con al menos 3 regiones, cada region comprende una composicion farmaceutica, con distancias entre dos regiones menores a distancias a otra configuracion CL2009000164A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6260308P 2008-01-28 2008-01-28
EP08001546A EP2082717A1 (en) 2008-01-28 2008-01-28 Titration package

Publications (1)

Publication Number Publication Date
CL2009000164A1 true CL2009000164A1 (es) 2009-12-18

Family

ID=39456418

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000164A CL2009000164A1 (es) 2008-01-28 2009-01-26 Envase de dosificacion para una composicion farmaceutica al menos en dosis diferentes, comprende al menos dos configuraciones tipo caja conectadas entre si, cada una con al menos 3 regiones, cada region comprende una composicion farmaceutica, con distancias entre dos regiones menores a distancias a otra configuracion

Country Status (12)

Country Link
US (1) US9314401B2 (es)
EP (2) EP2082717A1 (es)
JP (1) JP5588881B2 (es)
AR (1) AR070165A1 (es)
CL (1) CL2009000164A1 (es)
DE (1) DE202009018751U1 (es)
ES (1) ES2433097T3 (es)
MX (1) MX2010008005A (es)
PT (1) PT2244685E (es)
RU (1) RU2467737C2 (es)
SI (1) SI2244685T1 (es)
WO (1) WO2009095154A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120228190A1 (en) * 2011-03-11 2012-09-13 Anthony Joonkyoo Yun Multi-dose nutritional supplements for the promotion of joint health
US20120228176A1 (en) * 2011-03-11 2012-09-13 Anthony Joonkyoo Yun Multi-dose nutritional supplements
US20120228191A1 (en) * 2011-03-11 2012-09-13 Anthony Joonkyoo Yun Multi-dose nutritional supplements for the promotion of bone health
US11406563B2 (en) 2018-07-27 2022-08-09 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US974A (en) 1838-10-10 Improvement in grist-mills
US3276573A (en) * 1965-01-21 1966-10-04 Searle & Co Dispensing device for solid-form pharmaceutical preparations
US3381808A (en) * 1966-10-10 1968-05-07 Wallace & Tiernan Inc Dispensing package
EP0000208B1 (de) 1977-06-28 1980-04-30 BASF Aktiengesellschaft Verfahren zur Herstellung von Imidazolen
US4706815A (en) * 1982-08-23 1987-11-17 American Home Products Corporation Dispensing container for triphasic
US4534468A (en) * 1983-12-19 1985-08-13 Nuckols Walter S Calendar-oriented pill dispenser
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4958736A (en) 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
JP3117622B2 (ja) 1995-07-10 2000-12-18 東リ株式会社 軟質発泡広巾巾木
JP2662206B2 (ja) 1995-07-20 1997-10-08 日本イーライリリー株式会社 錠剤用容器
US5788974A (en) 1996-09-11 1998-08-04 D'amico; Steven A. Helicobacter pylori treatment compliance pack
JP2001070404A (ja) * 1999-06-28 2001-03-21 Dainabot Co Ltd プッシュスルーパック（ｐｔｐ）シートを収納するための台紙
US6273260B1 (en) * 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
US6752272B2 (en) * 2001-09-13 2004-06-22 Mead Westvaco Corporation Unit dose packaging system with exterior pocket feature
US7086532B2 (en) 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
US20040188316A1 (en) 2003-03-26 2004-09-30 The Procter & Gamble Company Kit for pharmaceutical use
JP4938456B2 (ja) * 2003-10-22 2012-05-23 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の薬剤パック
JP3117622U (ja) * 2005-09-22 2006-01-12 健一朗 中島 服用タイミング表示付き周回状ブリスターパック
WO2007109684A2 (en) * 2006-03-20 2007-09-27 Pre Holding, Inc. Dose packaging system for load-dose titration administration of a liquid formulation
JP2007282822A (ja) * 2006-04-17 2007-11-01 Invel:Kk 薬の服用管理方法
DE102007037374B4 (de) * 2007-08-06 2009-04-23 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern

Also Published As

Publication number Publication date
AR070165A1 (es) 2010-03-17
EP2244685B1 (en) 2013-07-31
EP2244685A1 (en) 2010-11-03
US20110039942A1 (en) 2011-02-17
RU2467737C2 (ru) 2012-11-27
JP2011510695A (ja) 2011-04-07
US9314401B2 (en) 2016-04-19
EP2082717A1 (en) 2009-07-29
WO2009095154A1 (en) 2009-08-06
ES2433097T3 (es) 2013-12-09
RU2010136278A (ru) 2012-03-10
MX2010008005A (es) 2010-08-10
DE202009018751U1 (de) 2013-03-19
JP5588881B2 (ja) 2014-09-10
SI2244685T1 (sl) 2013-12-31
PT2244685E (pt) 2013-09-23

Similar Documents

Publication Publication Date Title
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
BR112013011949A2 (pt) "indóis, composição farmacêutica que os compreende, seus processos de preparação e uso dos ditos indóis"
AR053292A1 (es) Un sistema de suministro para dos o mas componentes acivos como parte de una composicion comestible
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
GT200600258A (es) Derivados de n-(piridin-2-il)-sulfonamida
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
UY31918A (es) Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
BR112014029698A2 (pt) embalagem para lâmina limpadora
BR112015003234A2 (pt) sistema de dispensação de cartucho de duplo propósito
GT200600261A (es) Formulaciones de diclofenac y metodos para usarlas
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
BR112013024430A2 (pt) formulações compreendendo 2-amino-2-[2-(4-octilfenil)etil]propano-1,3-diol
PE20150353A1 (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
CL2009000164A1 (es) Envase de dosificacion para una composicion farmaceutica al menos en dosis diferentes, comprende al menos dos configuraciones tipo caja conectadas entre si, cada una con al menos 3 regiones, cada region comprende una composicion farmaceutica, con distancias entre dos regiones menores a distancias a otra configuracion
ECSP15010550A (es) Preparación farmacéutica sólida que contiene levotiroxina
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
UY32299A (es) Composiciones farmacéuticas líquidas
CL2016001707A1 (es) Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11).
BRPI1011851A2 (pt) Composto, composição farmacêutica, e, métodos para induzir apoptose em uma célula, epara tratar uma doença
PE20150278A1 (es) Agentes de aclareo que contienen diuron
BR112013017570A2 (pt) compostos de pirazola como antagonistas de crth2